Obviously you are attempting to affect the share price. Glad you are making money day trading just keep it to yourself. Your injecting of other trials in process is your attempt to scare people into selling and driving down the price to grab 2 or 3 k shares or more knowing it will go back up end of day to once again sell off for 10 to 15 cents/share. Over a period of time you can make real money as you are doing.
Idiot, menace or Genius?
I am the one that posted my trades and shorted $3.57 twice.
Other posters identified that Novartis has a competitive Hedgehog pathway medication.
That I might add gained FDA approval.
And that CRIS will receive a reduced royalty due to another med as the terms of their agreement was written.
I do not believe this board has any effect on the share price of CRIS.
At one time I thought Duckyah000 was an individual trying to manipulate CRIS stock. Now I realize that he is both an idiot and someone with nothing else to do but bounce around attempting to scare people of which he may have done. I suggest just ignore him and others like him. If the stock was tanking he, or anyone holding shares, would be the last to disclose bad news until they sold off.
he develops resistance to all therapies the MD tries pretty fast so poor MD has to try new one every time....lol
I am long, that's why I cheer
You play short and so you jeer.
I just go where the money flows.
That's just how this game goes.
You're a bear. I'm a bull.
Take it easy. Play it cool.
Man...I am good!
You gotta at least agree with that!
When I go out to dine I want to eat in a Brand New restaurant.
And when I see my MD he prescribes the newest medications.
Definitely a concern as a competitor. It may affect Erivedge sales in 6 mos. However, it's hard to tell without a side by side comparison as to whether one works better than the other. Because doctors are already comfortable with Erivedge, it may take a while before E sales may be affected. By then, Curis may have already been bought out.
Novartis Hedgehog Cancer Drug:
Treatment of medulloblastoma
Treatment of advanced basal cell carcinoma
Treatment of SOLID TUMORS
Novartis' new drug, which also has applications in brain cancer and solid tumors, is among 10 pipeline treatments and new indications Novartis' ambitious oncology.
Novartis competition med is saying the SAME!
A subset of medulloblastoma tumors briefly stopped growing or disappeared entirely during treatment with vismodegib; St. Jude Children’s Hospital led the Pediatric Brain Tumor Consortium trials in children and adults.
Memphis, Tennessee, July 29, 2015
Giles W. Robinson, MD
A targeted therapy already used to treat advanced skin cancer is also effective against the most common subtype of the brain tumor medulloblastoma in adults and should be considered for treatment of newly diagnosed patients, according to research led by St. Jude Children’s Research Hospital.
My crystal ball says CRIS 2% from everidge sales is toast and they will have to sell 10 million shares at the market to have enough cash for 908
But that will not be enough cash to hold them for more than 6 months if they are required by the FDA to do a pivotal PII trial for orphan status.
This company is an amazing short paradise.